CSIMarket
 


Vyant Bio Inc   (VYNT)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Vyant Bio Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Vyant Bio Inc asset turnover ratio, the ability of Vyant Bio Inc 's assets to generate revenue in the forth quarter 2022, increased sequentially to 0.03 in the fourth quarter (Dec 31 2022), yet the ratio remained below the average, as VYNT's position remain challenging.

Within sector 43 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Forth Quarter 2022 compared to the preceding quarter from 0 to 4140.


What is Asset Turnover Ratio?
What is Vyant Bio Inc Market Share?


VYNT Asset Turnover Ratio (Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Asset Change -61.17 % -62.37 % -60.3 % -55.08 % 350.84 %
Y / Y Revenue Change - -89.91 % -91.53 % 36.49 % -
Asset Turnover Ratio (TTM) 0.03 -0.06 -0.01 0.02 -
VYNT's Total Ranking # 4140 # 0 # 0 # 3849 # 4113
Seq. Asset Change -36.56 % -11.27 % -20.1 % -13.65 % -38.52 %
Seq. Revenue Change -69.74 % -7.88 % -45.54 % - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 44
Healthcare Sector # 661
Overall Market # 4140

Asset Turnover Ratio Statistics
High Average Low
5.09 2.43 -4.04
(Jun 30 2021)   (Sep 30 2022)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Sigilon Therapeutics Inc   0.12 $ 12.944  Millions$ 103.870  Millions
Fate Therapeutics Inc   0.12 $ 96.300  Millions$ 780.089  Millions
Genfit S a   0.12 $ 29.754  Millions$ 241.405  Millions
Regenxbio Inc   0.12 $ 112.724  Millions$ 923.968  Millions
Inspira Technologies Oxy B h n Ltd   0.12 $ 1.951  Millions$ 16.012  Millions
2seventy Bio Inc   0.12 $ 91.496  Millions$ 751.184  Millions
Alpine Immune Sciences Inc   0.12 $ 30.064  Millions$ 257.012  Millions
Morphosys Ag  0.12 $ 311.659  Millions$ 2,684.564  Millions
Aclaris Therapeutics Inc   0.12 $ 29.752  Millions$ 256.683  Millions
Regenerx Biopharmaceuticals inc   0.12 $ 0.077  Millions$ 0.665  Millions
Isoplexis Corporation  0.12 $ 16.528  Millions$ 143.250  Millions
Lineage Cell Therapeutics Inc   0.11 $ 14.703  Millions$ 133.814  Millions
Nektar Therapeutics  0.11 $ 92.055  Millions$ 844.427  Millions
Edgemode Inc   0.11 $ 0.438  Millions$ 4.044  Millions
Vectivbio Holding Ag  0.11 $ 27.341  Millions$ 252.599  Millions
Galapagos Nv  0.11 $ 565.914  Millions$ 5,302.473  Millions
Sinovac Biotech Ltd  0.11 $ 1,492.761  Millions$ 14,114.568  Millions
Xenetic Biosciences Inc   0.11 $ 1.707  Millions$ 16.186  Millions
Inventiva S a   0.10 $ 13.640  Millions$ 129.924  Millions
Bridgebio Pharma Inc   0.10 $ 77.648  Millions$ 756.790  Millions
Icecure Medical Ltd   0.10 $ 3.085  Millions$ 30.188  Millions
Cytokinetics Incorporated  0.10 $ 94.588  Millions$ 929.677  Millions
Precision Biosciences Inc  0.10 $ 25.098  Millions$ 247.104  Millions
Aeterna Zentaris Inc   0.10 $ 5.640  Millions$ 56.026  Millions
Merus N v   0.10 $ 41.586  Millions$ 413.456  Millions
Theravance Biopharma inc   0.10 $ 51.346  Millions$ 521.754  Millions
Pear Therapeutics Inc   0.10 $ 12.694  Millions$ 132.369  Millions
Arvinas Inc   0.10 $ 131.400  Millions$ 1,374.725  Millions
Precigen Inc   0.10 $ 26.909  Millions$ 283.004  Millions
Aadi Bioscience Inc   0.09 $ 15.216  Millions$ 162.324  Millions

Date modified: 2023-04-24T20:08:15+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com